Bortezomib induces osteoblast differentiation via Wnt-independent activation of β-catenin/TCF signaling
Open Access
- 30 April 2009
- journal article
- research article
- Published by American Society of Hematology in Blood
- Vol. 113 (18) , 4319-4330
- https://doi.org/10.1182/blood-2008-08-174300
Abstract
Inhibition of Wnt/β-catenin/T-cell factor (TCF) signaling induces proliferation of mesenchymal stem cells and/or suppresses their differentiation intKeywords
This publication has 61 references indexed in Scilit:
- The role of Dickkopf-1 in bone development, homeostasis, and diseaseBlood, 2009
- Wnt3a signaling within bone inhibits multiple myeloma bone disease and tumor growthBlood, 2008
- Myeloma-derived Dickkopf-1 disrupts Wnt-regulated osteoprotegerin and RANKL production by osteoblasts: a potential mechanism underlying osteolytic bone lesions in multiple myelomaBlood, 2008
- Serum concentrations of DKK‐1 correlate with the extent of bone disease in patients with multiple myelomaEuropean Journal of Haematology, 2008
- Increasing Wnt signaling in the bone marrow microenvironment inhibits the development of myeloma bone disease and reduces tumor burden in bone in vivoBlood, 2008
- Pharmacologic targeting of a stem/progenitor population in vivo is associated with enhanced bone regeneration in miceJournal of Clinical Investigation, 2008
- The oxidative stress response regulates DKK1 expression through the JNK signaling cascade in multiple myeloma plasma cellsBlood, 2007
- Antibody-based inhibition of DKK1 suppresses tumor-induced bone resorption and multiple myeloma growth in vivoBlood, 2006
- Expression of receptor activator of NF-?B ligand (RANKL) mRNA in human multiple myeloma cellsZeitschrift für Krebsforschung und Klinische Onkologie, 2004
- Human Osteoblasts Express a Repertoire of Cadherins, Which Are Critical for BMP-2–Induced Osteogenic DifferentiationJournal of Bone and Mineral Research, 1998